1 year return (CAGR)
30.42%
Sagimet Biosciences Inc. Series A Common Stock Exchange (NASDAQ, USD)
SGMT
9.92
-0.02 (-0.21%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
27.89%
5 year return (CAGR)
-
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
672.46M
Price/Sales
-
Ent value
513.84M
Price/Book
2.63
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
25.21%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 9.61 |
| Daily high | 9.70 |
| Daily low | 9.41 |
| Daily Volume | 767K |
| All-time high | 18.42 |
| 1y analyst estimate | 27.91 |
| Beta | 3.49 |
| EPS (TTM) | -0.89 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| SGMT | S&P500 | |
| Current price drop from All-time high | -46.15% | -3.00% |
| Highest price drop | -89.69% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -64.26% | -10.65% |
| Avg time to new high | 118 days | 12 days |
| Max time to new high | 694 days | 1805 days |
News
